article thumbnail

Algernon Pharmaceuticals Announces LOI for the Acquisition of its Chronic Cough Research Program by U.S. Based Seyltx for USD $2M and a 20% Equity Position

Global Newswire by Notified: M&A

22, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it has signed a Letter of Intent (“LOI”) with Seyltx Inc. VANCOUVER, British Columbia, Nov.

article thumbnail

E200: Buying or Selling a Small Business? Get the Insider Tips You Need to Secure Your Deal

How2Exit

With a career spanning over a decade, Patrick has become an industry-agnostic specialist, facilitating financial diligence, quality of earnings, purchase price negotiation, and offering comprehensive partnership support to his clients. rn rn rn Emotional readiness and concessions are critical in M&A transactions.

Business 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Delaware Court Of Chancery Dismisses Breach Of Contract Claims Against Buyer, Finding Seller Retained Post-Closing Liability Related To Certain Product-Liability Litigations

Shearman & Sterling

Cook of the Delaware Chancery Court dismissed the breach of contract claims by one pharmaceutical company (the "Seller") against another (the "Buyer") in connection with the Buyer's acquisition of Seller's consumer product lines in 2014 pursuant to a Stock and Asset Purchase Agreement (the "Agreement').

article thumbnail

Delaware Court Of Chancery Dismisses Breach Of Contract Claims Against Buyer, Finding Seller Retained Post-Closing Liability Related To Certain Product-Liability Litigations

Shearman & Sterling

Cook of the Delaware Chancery Court dismissed the breach of contract claims by one pharmaceutical company (the "Seller") against another (the "Buyer") in connection with the Buyer's acquisition of Seller's consumer product lines in 2014 pursuant to a Stock and Asset Purchase Agreement (the "Agreement').

article thumbnail

What is Freight on Board (FOB)? Origin vs. Destination

Peak Frameworks

company like Tesla, understanding terms like FOB is crucial when negotiating deals and supply contracts overseas. Consider a pharmaceutical giant like Pfizer , which imports raw materials for its drugs. Contractual Implications Negotiating with terms like FOB in mind can lead to more favorable deals.

article thumbnail

Artificial intelligence: is it good or bad for society?

Growth Business

In many ways, this is a good thing that will help the pharmaceutical industry detect and understand disease. What AI is doing for us now AI is already able to drive vehicles and negotiate obstacles. With so many resources being dedicated to its development and no real obstacles predicted, its rapid development is set to continue.

IT 52
article thumbnail

Cooley’s 2022 Life Sciences M&A Year in Review

Cooley M&A

But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions.

M&A 40